CIK 0001615219 · Non-accelerated filer<br>Smaller reporting company
Decoy Therapeutics Inc.
Sign in to watch- Ticker
- DCOY
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 465087339
- Phone
- 346-772-0346
- Business address
- 2450 HOLCOMBE BLVD, SUITE J-608, HOUSTON, TX, 77021
- Former names
- Salarius Pharmaceuticals, Inc., Flex Pharma, Inc.
- 8-K/A Event Exhibits
- 8-K Event Material agreement · Unregistered share sale · Shareholder rights changed
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Grant or award Chief Executive Officer acquired 4,879 shares (grant or award)
- 4 Grant or award Exec VP Finance, CFO acquired 4,723 shares (grant or award)
- 8-K Event Delisting notice
- 4 Open-market buy Director bought 4,000 shares at $0.98 ($3,920)
- 4 Open-market buy Chief Executive Officer bought 2,000 shares at $1.01 ($2,020)
- 4 Open-market buy Exec VP Finance, CFO bought 5,000 shares at $1.00 ($5,000)
- S-8 Other Securities Offered to Employees in Benefit Plans
- 8-K Event Results of operations
Page 16 of 38 · 744 filings